[144] SEMPRA SEC Filing

Rhea-AI Filing Summary

Sempra (SRE)500 shares of common stock through broker Oppenheimer & Co., Inc. on the NYSE, with an indicated aggregate market value of $45,800.00. The filing states that there were 652,681,521 shares of Sempra common stock outstanding at the time of the notice.

The 500 shares to be sold were acquired on 01/28/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as compensation. The same insider previously sold 5,500 shares of Sempra common stock on 11/18/2025 for gross proceeds of $503,696.00.

11/19/2025 - 06:52 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	500	45800.00	652681521	11/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/28/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			500	01/28/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Caroline A. Winn 488 8th Avenue San Diego CA 92101	Common Stock	11/18/2025	5500	503696.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sempra (SRE)'s latest Form 144 filing disclose?

The Form 144 filing for Sempra (SRE) discloses an insider’s intent to sell 500 shares of Sempra common stock on the NYSE through Oppenheimer & Co., Inc., with an indicated aggregate market value of $45,800.00.

How many Sempra (SRE) shares are covered by this Form 144 and what is their market value?

The notice covers 500 shares of Sempra common stock with an aggregate market value of $45,800.00 as stated in the filing.

How and when were the Sempra (SRE) shares being sold acquired by the insider?

The 500 shares were acquired on 01/28/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as compensation.

What prior Sempra (SRE) share sales by this insider are disclosed in the last three months?

The filing reports that the insider sold 5,500 shares of Sempra common stock on 11/18/2025, generating $503,696.00 in gross proceeds.

Which broker and exchange are involved in the Sempra (SRE) Form 144 sale?

The proposed sale of 500 Sempra common shares is to be executed through broker Oppenheimer & Co., Inc. on the NYSE, as indicated in the Form 144.

How many Sempra (SRE) shares were outstanding at the time of the Form 144 notice?

The filing states that 652,681,521 shares of Sempra common stock were outstanding at the time of the notice.